Hospitalist Doctors in Milton, MA Accepting Medicare

6 Hospitalist doctors found. Showing 1 - 6

Afrin Mustafa Farooq, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-754-0748    Fax: 617-754-0701

Sara Mohammed, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377    Fax: 617-754-8632

Hans Chiang, MD, MBA, MS Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377

Dr. Marzio Napolitano, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377

Bonnie Cao, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-696-4600

Dr. Saifullah Muhammad Shahid, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 199 Reedsdale Road, Milton, MA 02186 Phone: 617-696-4600

News Archive

Umea University researchers find link between vitamin E and brain tumours

Researchers at Umea University in Sweden and the Cancer Registry of Norway have studied possible causes behind the development of brain tumours.

Scientists use nanoscale polymer films to control drug delivery

Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.

SOM Biotech closes first financing round and files patent application

SOM Biotech, a biopharmaceutical start-up company with a business model centered on the identification and development of drug repurposing opportunities, reports significant progress on its trajectory towards pipeline development and candidate outlicensing.

Opexa's Tovaxin Phase IIb study data in MS presented at AAN meeting

Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.

Read more Medical News

› Verified 5 days ago